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Abstract 
A prospective study on the prevalence of HIV-l infection in Karachi, Pakistan was conducted over a
period of six years (1986-1992). Over 15,000 individual samples and more than 32,000 donor units of
individuals residing in Karachi at the time of sample collection were tested for HIV-I infection by our
screening test EIA which revealed a positivity rate of 0.23% and 0.003% in individual and donor units
respectively by Western Blot. We divided patients into four groups A,B,C and D based on the most
plausible cause of transmission. The largest number of positive patients belonged to group B, who were
of either foreign origin or expatriates or Pakistanis sett led abroad. They comprised approximately 67%
of the total positive cases and were subjected to testing on strong clinical grounds. In individuals of
other groups like group A and D, there was history of travel abroad from time to time. The only
positive donor unit (group C) belonged to a person who had been living in Middle East for the last 10-
12 years. The last group D comprised of samples that were directly sent to us without complete history,
except for the fact that they had been travelling back and forth. The large majority of patients fell in 20-
50 years age group. Despite the limitations of this study, we conclude that the prevalence of HIV is
steadily Increasing in our population and so far, we have not been able to find an indigenous case of
AIDS in our series (JPMA 44: 8, 1994).
Introduction 
The first case of Acquired Immunodeficiency Syndrome (AIDS) in Pakistan was reported in 1987. A
condition initially reported among homosexual men in Los Angeles, USA with subsequent isolation of
Human Immunodeficiency Virus (HIV-I) in 19831. As of July 1, 1992, a cumulative total of 501,272
cases of Acquired Immunodeficiency Syndrome have been reported to WHO from 168 countries. WHO
estimates that at least 10-12 million adults to date have been infected with HW, out of these, 1.5 million
have full blown spectrum of AIDS. Since the beginning of the epidemic, 1 million children worldwide
have been infected with the HIV-I. Out of these 12 million, approximately 1 million persons were
infected during the first six months of 1992, about one half residing in sub-Saharan Africa and a quarter
in Asia2. The present number of AIDS cases reflect the HIV infection acquired almost a decade ago.
Taking into account under-reporting and delay in reporting WHO estimates that the actual number of
adult cases may be closer to 1.7 million. With every passing day, 5,000 more people worldwide become
infected with the virus3. The projection for the future is that by year 2,000, 30-40 million people will be
infected with HIV 90% of those infections will occur in developing countries. AIDS could undermine
decades of progress in health and economics in the third world countries. Many of these countries lack
funds necessary for AIDS surveillance and this may lead to under-diagnosis and under- estimation4.
There is paucity of AIDS data and studies in Pakistan, apart from few published studies5,6.
Materials and Methods 
A prospective analysis of serum samples and donors screened for HW-I infection by enzyme immuno-
assay serum samples (EIA) was carried out during the period June, 1986 to June, 1992. A total of
15,639 individuals and 32,127 donors (Table)
were screened. The former group included 14,097 individuals who were screened for immigration
purposes only. Another sub-set of 145 patients were referred as suspected cases of RW positive
Dy/AIDS for laboratory testing. 1,240 samples belonged to individuals on whom complete clinical
information was not available.
All positive test samples were sent for confirmation to National Institute of Health, Islamabad, after
retesting for positive reactivity, in duplication at our institution.  The confirmation was done by
Western Blot (WB) (Bio-Rad), the results were interpreted using  criteria as set by WHO. The testing
for blood donors was introduced in 1987 at our Medical Centre and we are one of the few centers in the
country where regular testing for HW-I is carried out on blood products. Abbott Recombinant HIV-I
EJA is an in-vitro enzyme immunoassay for the detection of antibody to HP/-I in human serum or
plasma. This test detects antibodies directed against 2 major groups of HIV-I proteins envelope and
core. The WB is used to confirm the presence of HP/-I infection as it permits the identification of
antibodies to individual component polypeptide of 1-1W-I7. Although the specificity of most ELISA
for antibodies to HIV exceeds 99.8%, they are often used to test population with a very low prevalence
of H1V infection. In these circumstances, the positive predictive value of the test may be 10% or even
less. It is critically important to employ supplementary test procedures to  validate the HTV infection
status of individuals with reactive screening test results. It must be realized that false positive screening
test results will generally occur with the same frequency in any population tested. Therefore, even
population with a high prevalence of HW infection, some screening test results will show false positive
results8. Repeating the initially reactive EIA increases the apparent specificity of the test. False positive
ETA result may be caused by specimen immunoglobulin non-specifically adsorbed to the solid phase
reaction vessel. Also, they may occur as a result of cross- reactive antibodies directed to antigen
determinants found in non-pathogenic retroviruses, or to antibodies to lymphocyte antigens derived
from the human cells in which the ELISA antigen is propagated8,9. There are variety of methods for
confirmation of 11W screening assays. Currently, however, WB test and indirect immune fluorescence
are most frequently used for this purpose.
Results 
A total of 51 samples (41 males, 10 females) were positive by ETA; of these, 30 males and 6 females
were confirmed to be antibody positive by WB. The ages ranged from 18 days to 67 years. A total of 9
patients -6 males and 3 females, revealed no bands on WB. The WB of one patient was indeterminate.
The results of three patients are awaited and one patient sample was lost during shipment and another
was of insufficient quantity for analysis.
The patients and donor confirmed to have 11W infection as demonstrated by WB were divided into the
following groups. These individuals had strong clinical suspicion and were tested because of this
reason. This group comprised the largest number of positive cases.
Group A
Screened for immigration purposes: A total of 14,097 individuals were tested. Six individuals were
positive on the screening test, but only one was confirmed positive. This particular individual had been
travelling back and forth from Pakistan to North America.
Group B
The individuals in this group were further categorized based on the most plausible cause of acquiring
HW infection.
Sub-group 1- Foreigners/Pakistanis settled abroad
This group comprised of all those patients who were either expatriates or foreigners, 8 patients were
from Africa (Uganda, Tanzania), 6 had been working in the Middle East (UAE, Saudi Arabia) and one
was of Indian origin, living in Paris. One Nepalese male and one American were also present in this
group. Interestingly, the only confirmed donor was also an expatriate as discussed later.
Sub-group 2 - Frequent travel abroad
Included in this category were 3 individuals whose job involved very frequent visits to various parts of
the world.
Sub-group 3-Recipients of multiple transfusions
The individuals of this group included a haemophiliac and a patient with thalassemia major. The third
individual apparently had undergone cardiac bypass surgery in London in 1982, when screening of
blood products for 11W infection was non-existent. Similarly, the above patient of thalassemia had
been receiving transfusions in the Middle East, where most of the blood till 1985 was imported from
abroad. The screening of blood products came into full play in 1985, in USA.
Sub-group 4- Family members/close contacts
At the moment, two cases of HW transmission to spouses are present in our record, heterosexual trans-
mission being the most probable cause.
Sub-group 5- Vertical transmission
There is so far only one possible case of this pattern in our observation, where the mother had possibly
acquired the infection in a Middle East country after receiving multiple transfusions during a previous
surgical procedure. An 18 days old infant tested positive for 11W antibodies. However, these could
have been maternal antibodies and for confirmation polymerase chain reaction for 11W DNA sequence
or culture is required at this stage. The other choice would be to recheck for the presence of antibodies
in the infant at the age of 15-18 months. If the antibodies persist at this time then the presence of
infection is confirmed.
Group C-Donors
Three donors were initially reactive on screening by ELISA, but only one was confirmed by WB. This
particular individual had been living in UAE for the last 10-12 years.
Group D - Direct referrals
Individuals in this group had no definite history available, apart from the fact that they had been outside
Pakistan at sometime or the other. They were referred either from outside laboratories or other cities. At
the time of this writing, five more individuals have been tested positive by ETA. Confirmatory results
are awaited. Three (2 males, 1 female) belong to sub-group 1 and 2 persons (1 male, 1 female) belong
to sub-group 3. Since June, 1292 to October 31, 1992 more than 1,150 patient samples, 2,500 donor
samples have been screened for 11W-I infection. The cases in which indeterminate results were
obtained on WB those patients were requested to submit samples again at three and six month interval.
Unfortunately these few individuals in our case were lost to follow-up.
Discussion 
In Pakistan, according to the official statistics, more than 250,000 individuals have been screened for
HIV-I infection and a total of 129 cases of sero-positivity have been detected so far. Nineteen
individuals developed AIDS, out of them 17 have died and two are still alive10. A conservative estimate
by WHO indicates over 1 million infections in South and South-East Asia, the vast majority of them in
India and Thailand. Abdul Mujeeb et al reported that during 1986-87, 1,363 subjects were screened for
HIV infection in Karachi, 2 were confirmed positive by WB5. These two were married females who
had received multiple transfusions and denied other risk factors. Khanani et al reported another 3
confirmed cases of HJV infection in a group of 413 screened individuals from Karachi in 19906. Two
were foreign nationals of Tanzania and Uganda and third individual was a Pakistani national residing in
Saudi Arabia who had received multiple transfusions following a car accident in 1981. As stated earlier,
till June 1992, we have screened a total of 47,766 serum samples. These samples represent a variable
and significant segment of our population. The noteworthy point in this context is that none of the
above confirmed HIV positive patients represent indigenous case of AIDS in Pakistan. The largest
group of positive patients is represented by foreigners/expatriates, individuals with frequent travel
history and recipients of multiple transfusions. The common denominator in all these cases is the fact
that HW infection was acquired outside Pakistan by different modes during their long or short stay
abroad. Some of the confirmed cases further transmitted it to their spouses. One of the donor sample
confirmed for HW infection belonged to an individual living outside Pakistan in UAE for the last 10-12
years. All our positive cases depict the classical modes of transmission of HIV-I virus11. The data also
shows an increase in the number of HIV-I positivity. In the first year June 1986-June 1987, 5
individuals were positive for HIV-I infection whereas in the last year, July 1991-June 1992, 12 cases of
HIV-I positivity were demonstrated. Most of the positive individuals fell into the 20-50 years age
group. Asia was labelled as having no specific mode of transmission of HIV-I virus in a study
conducted in 1988 by WHO, whereas patterns I and II were assigned to USA, western Europe and sub-
Saharan Africa respectively12. Heterosexual transmission was declared as the dominant mode of spread
in Africa and homosexual and intravenous drug abusers were involved in spread of disease in the
Western countries including USA. The epidemiological picture has now changed. On March F, 1989,
141,894 AIDS cases were reported to WHO Global Programme on AIDS from 145 countries. 70% of
the world total cases were from America, 85% of these from USA13, but presently, the sub-Saharan
Africa has the largest number of HIV infected individuals and itis projected that by year 2000, Asia will
account for 42% of HIV infections2. 90% of those with AIDS in developing countries and industrial
countries are between the ages of 20-494. The present regional distribution of cumulative adult
HP/infections, based on WHO statistics indicates that sub-Saharan Africa has over 7 million infections;
North America and Latin America, including the Caribbean, have over 2 million; South and South East
Asia have over 1 million, followed by Europe, North Africa, Middle East, Australia, East Asia and
Pacific. AIDS has no doubt reached epidemic proportions in the third world and 1.5 million new cases
predicted for this decade will be coming from the third world2. Most of the under- reported cases are in
the third world where cultural taboos, government attitudes and shortage of money often hamper the
reporting process14. The third world government lack the equipment and funds necessary for AIDS
surveillance. Diverting funds for AIDS education is not priority in third world where leading causes of
death continue to be diarrhoea, malaria, etc. It is stated that the presence of a pre-existing sexually
transmitted disease increases the risk of HIV transmission by sexual intercourse. The most common
means of HIV transmission is now heterosexual contact and if left unchecked will continue to be the
main means of spread in Asia. India and Thailand with their rapidly increasing number of AIDS
patients have well supported these facts. The adult population in South and South East Asia is 500
million as compared with 225 million in sub Saharan Africa, therefore, the pandemic may grow at a
much faster rate in our part of the world. In developing countries of Africa, Asia and Latin America, the
ratio of infection in men and women is almost equal or rapidly becoming so, indicating the
predominance of heterosexual transmission. WHO estimates that nearly one half of new adult
infections have occurred among women. Recent estimates have indicated that 2.1-6.7 million Thais will
be infected by year 2000. It is presently estimated that India has 2.7 million HIV positive cases. In a
study conducted in India to determine the incidence of HIV infection in hemophiliac patients and those
receiving multiple transfusions, 16 out of 124 individuals were positive for HW infection15. In another
study from India, 182 vials of commercially available blood products revealed 32 products to be
positive for HP/antibodies. These products are prepared from blood collected from professional
donors16. It is of utmost importance to prevent transmission through blood products in our country. In
Pakistan, the practice of screening of blood products for HIV infection is practically absent. Only a few
large medical centres in the country are screening blood products. It is essential to screen all blood
products. The risks in the Western countries have been minimized by screening all donated blood and
heat treatment of blood factors VIII and IX. In the United States where every blood unit is screened, the
statistical incidence of transfusion associated AIDS is estimated to be 1 in 1,25,000 blood donations17.
The risk of acquiring HW infection through transfusion is approximately 1 in 153,000 per
component18. Thus mandatory testing of blood products should be strictly enforced by governmental
agencies in Pakistan to limit the progress of this disease. Similarly, use of blood from professional
donors needs to be eliminated. Our data depicts the number of HW-I positive individuals in a cross-
section of our population. As the samples were collected from individuals residing temporarily or
permanently in Karachi at the time of sample collection one may speculate that the results are of
reflection of pattern not only in Karachi but of the country as well. Further studies to determine the
prevalence in high risk groups is essential. A recent study19  elicited that more than 33,000 samples
were tested out of which fifteen were confirmed to carry HW-I infection by \\VB. These cases
represented external source, i.e., outside Pakistan as a cause. It is also stated that a definite increase in
the number of positive cases is seen after 1990. The official number of known cases of sero positivity
in Pakistan is presently only 129 as of June 1992. Nevertheless, proper health education has to be
delivered to the public. It is strongly recommended that the news media, radio, television, social
workers, health care workers and politicians should create public awareness. Methods of preventing the
spread should be publicized. Sero-surveillance of selected segments of population to assess the current
AIDS situation and to monitor progression of 11W should be carried out. Despite the limitations and
shortcomings of our study, we strongly feel that there is an increase in HW-I infection in Pakistan and
there is no proven indigenous case of AIDS in our series. High risk behaviour groups should be
screened to assess the true prevalence of this infection.
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